Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Seth H PincusDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA.ORCID 0000-0003-1622-4386
Kun LuoDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Tami PetersDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA.
James T GordyDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0003-2588-0756
Frances M ColeDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA.
Grant KlugDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA.ORCID 0000-0003-0909-8588
Kelli OberDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA.
Tamera K MarcotteAnimal Resources Center, Montana State University, Bozeman, MT 59715, USA.
Richard B MarkhamDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0003-3527-9147
Funding
Cytotoxic immunoconjugates to deplete persistent HIV reservoirsR01AI136758 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI HARRINGTON, ROBERT D., PINCUS, SETH H. · 2018 to 2022
$3.5M
Development of transformed lactobacilli as a microbicideR21AI079794 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARKHAM, RICHARD B. · 2009 to 2010
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of · full record | OpenQuestion